View in EDS PDF Full Text

Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.
Authors: Bendell JC; Sarah Cannon Research Institute, Nashville, TN, USA. jbendell@tnonc.com, Ervin TJ, Gallinson D, Singh J, Wallace JA, Saleh MN, Vallone M, Phan SC, Hack SP
Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2013 Sep; Vol. 12 (3), pp. 218-22. Date of Electronic Publication: 2013 Jun 27.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23810377
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bendell+JC%22">Bendell JC</searchLink>; Sarah Cannon Research Institute, Nashville, TN, USA. jbendell@tnonc.com<br /><searchLink fieldCode="AU" term="%22Ervin+TJ%22">Ervin TJ</searchLink><br /><searchLink fieldCode="AU" term="%22Gallinson+D%22">Gallinson D</searchLink><br /><searchLink fieldCode="AU" term="%22Singh+J%22">Singh J</searchLink><br /><searchLink fieldCode="AU" term="%22Wallace+JA%22">Wallace JA</searchLink><br /><searchLink fieldCode="AU" term="%22Saleh+MN%22">Saleh MN</searchLink><br /><searchLink fieldCode="AU" term="%22Vallone+M%22">Vallone M</searchLink><br /><searchLink fieldCode="AU" term="%22Phan+SC%22">Phan SC</searchLink><br /><searchLink fieldCode="AU" term="%22Hack+SP%22">Hack SP</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101120693%22">Clinical colorectal cancer</searchLink> [Clin Colorectal Cancer] 2013 Sep; Vol. 12 (3), pp. 218-22. <i>Date of Electronic Publication: </i>2013 Jun 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101120693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215330028%22">15330028 </searchLink><i>NLM ISO Abbreviation: </i>Clin Colorectal Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23810377
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clcc.2013.04.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 218
    Titles:
      – TitleFull: Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bendell JC
      – PersonEntity:
          Name:
            NameFull: Ervin TJ
      – PersonEntity:
          Name:
            NameFull: Gallinson D
      – PersonEntity:
          Name:
            NameFull: Singh J
      – PersonEntity:
          Name:
            NameFull: Wallace JA
      – PersonEntity:
          Name:
            NameFull: Saleh MN
      – PersonEntity:
          Name:
            NameFull: Vallone M
      – PersonEntity:
          Name:
            NameFull: Phan SC
      – PersonEntity:
          Name:
            NameFull: Hack SP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2013 Sep
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0674
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical colorectal cancer
              Type: main
ResultId 1